期刊文献+

翻译后修饰Tau蛋白及其化学全/半合成

Chemical Synthesis/Semisynthesis of Post-Translational Modified Tau Protein
原文传递
导出
摘要 Tau蛋白是一种微管相关蛋白,有6种亚型,由352~441氨基酸组成。Tau蛋白的错误折叠和聚集与Tau蛋白病(Tauopathies),如阿尔茨海默病(AD)密切相关。目前在临床患者样本中可检测到具有各种翻译后修饰的Tau蛋白,这些翻译后修饰可能是AD发病机制的关键因素。本文综述了Tau蛋白常见的翻译后修饰,尤其是退行性疾病相关的翻译后修饰,以及化学全/半合成制备具有特定位点修饰、均一的Tau蛋白的进展。通过回顾翻译后修饰Tau蛋白的研究,可以更深入理解翻译后修饰对Tau蛋白的生理和病理作用,阐明翻译后修饰的调控机制,为相关疾病诊疗研究打下基础。 Tau protein is a microtubule-associated protein that contains six isoforms and consists 352~441 amino acids.Misfolding and aggregation of Tau protein are closely related to Tauopathies,including Alzheimer’s disease(AD).In the brain of AD patients,it is indicated that post-translational modification plays a key factor in the pathogenesis of AD.This paper reviews the post-translational modifications of Tau protein and the progress in chemical synthetic/semisynthetic preparation of uniform Tau protein with specific site modification.Reviewing the research of post-translational modification of Tau protein,clarifies the regulatory mechanism of posttranslational modification,which will help us to understand the physiological and pathological effects of posttranslational modification on Tau protein and further develop potential disease treatment methods.
作者 林业竣 李艳梅 Yehjun Lim;Yanmei Li(Department of Chemistry,Key Laboratory of Bioorganic Phosphorus Chemistry and Chemical Biology(Ministry of Education),Tsinghua University,Beijing 100084,China;Beijing Institute for Brain Disorders,Capital Medical University,Beijing 100069,China;Center for Synthetic and System Biology,Tsinghua University,Beijing 100084,China)
出处 《化学进展》 SCIE CAS CSCD 北大核心 2022年第8期1645-1660,共16页 Progress in Chemistry
基金 国家重点研发计划(No.2018YFA0507600,2019YFA0904200) 国家自然科学基金项目(No.92053108)资助。
关键词 TAU蛋白 Tau蛋白病 翻译后修饰 蛋白合成 蛋白半合成 Tau protein Tauopathies post-translational modification protein synthesis protein semisynthetic
  • 相关文献

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部